Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling-Reference-Cited by-同舟云学术

Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling

Published:2023-09-19 Issue:1 Volume:45 Page:98-111
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Yang Shuang,Li Hou-wei,Tian Jia-ying,Wang Zheng-kai,Chen Yi,Zhan Ting-ting,Ma Chun-yue,Feng Min,Cao Shi-feng,Zhao Yu,Li Xue,Ren Jing,Liu Qian,Jin Lu-ying,Wang Zhi-qi,Jiang Wen-yu,Zhao Yi-xiu,Zhang Yan,Liu Xue

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.nature.com/articles/s41401-023-01155-x.pdf

Reference48 articles.

1. Moussa ID, Mohananey D, Saucedo J, Stone GW, Yeh RW, Kennedy KF, et al. Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol. 2020;76:1521–31.

2. Yang X, Yang Y, Guo J, Meng Y, Li M, Yang P, et al. Targeting the epigenome in in-stent restenosis: from mechanisms to therapy. Mol Ther Nucleic Acids. 2021;23:1136–60.

3. Giacoppo D, Alfonso F, Xu B, Claessen BEPM, Adriaenssens T, Jensen C, et al. Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis. J Am Coll Cardiol. 2020;75:2664–78.

4. Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, et al. Coronary in-stent restenosis: JACC state-of-the-art review. J Am Coll Cardiol. 2022;80:348–72.

5. Zeng Z, Xia L, Fan S, Zheng J, Qin J, Fan X, et al. Circular RNA CircMAP3K5 acts as a microRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation. Circulation. 2021;143:354–71.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble expression of hMYDGF was improved by strain engineering and optimizations of fermentation strategies in Escherichia coli;Protein Expression and Purification;2024-12

2. Myeloid-derived growth factor in diseases: structure, function and mechanisms;Molecular Medicine;2024-07-19

3. Kanglexin counters vascular smooth muscle cell dedifferentiation and associated arteriosclerosis through inhibiting PDGFR;Phytomedicine;2024-07

4. Is myeloid-derived growth factor a ligand of the sphingosine-1-phosphate receptor 2?;Biochemical and Biophysical Research Communications;2024-04

5. Is myeloid-derived growth factor a ligand of the sphingosine-1-phosphate receptor 2?;2024-02-24